RN7SL812P

Across TCGA pan-cancer cohorts, RN7SL812P RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RN7SL812P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL812P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL812P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC, THCA, and LIHC are the cancer types where RN7SL812P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL812P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.214	<.001	9	view →
THCA	Female	All	−0.422	<.001	7	view →
LIHC	All	All	+0.162	<.001	7	view →
BLCA	All	All	+0.431	.006	6	view →
KIRP	Male	II,III,IV	+0.323	.002	6	view →
KICH	All	IV	+0.520	<.001	5	view →
LUSC	All	All	+0.518	<.001	5	view →
CHOL	All	All	+0.625	.002	4	view →
HNSC	Male	All	+0.269	<.001	4	view →
COAD	All	II,III,IV	+0.240	.001	4	view →
LUAD	All	All	+0.325	.006	2	view →
BRCA	Female	All	+0.187	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RN7SL812P–KIRC

Open the KIRC breakdown →